BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 987420 CC(C)Cn1c2nc(COc3cccc4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H32N4O4/c1-18(2)16-31-25-24(26(33)30(3)27(31)34)28-21(13-5-4-8-15-32)22(29-25)17-35-23-14-9-11-19-10-6-7-12-20(19)23/h6-7,9-12,14,18,32H,4-5,8,13,15-17H2,1-3H3 AAEUEFWLAISCKK-UHFFFAOYSA-N 476240 US10874675, Example 2 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476240&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023136 442076305 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987421 CC(C)Cn1c2nc(COc3cccc4cnccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(9-5-4-6-13-32)21(29-24)16-35-22-10-7-8-18-14-27-12-11-19(18)22/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 FIHHWLWMXIZNFC-UHFFFAOYSA-N 476241 US10874675, Example 3 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476241&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023137 442076306 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987422 CC(C)Cn1c2nc(COc3cccc4ncccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(10-5-4-6-14-32)21(29-24)16-35-22-12-7-11-19-18(22)9-8-13-27-19/h7-9,11-13,17,32H,4-6,10,14-16H2,1-3H3 ANJPRASHQRBVNB-UHFFFAOYSA-N 476242 US10874675, Example 4 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476242&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023138 442076307 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987423 CC(C)Cn1c2nc(COc3cncc4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(11-5-4-8-12-32)21(29-24)16-35-22-14-27-13-18-9-6-7-10-19(18)22/h6-7,9-10,13-14,17,32H,4-5,8,11-12,15-16H2,1-3H3 XGXCZTIKSVRCFZ-UHFFFAOYSA-N 476261 US10874675, Example 5 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476261&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023151 442076326 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987424 CC(C)Cn1c2nc(COc3cccc4[nH]ccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C25H31N5O4/c1-16(2)14-30-23-22(24(32)29(3)25(30)33)27-19(8-5-4-6-13-31)20(28-23)15-34-21-10-7-9-18-17(21)11-12-26-18/h7,9-12,16,26,31H,4-6,8,13-15H2,1-3H3 ATPOUOURVYPLOY-UHFFFAOYSA-N 476263 US10874675, Example 6 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476263&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023153 442076328 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987425 CC(C)Cn1c2nc(COc3ccccc3C(F)(F)F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29F3N4O4/c1-15(2)13-31-21-20(22(33)30(3)23(31)34)28-17(10-5-4-8-12-32)18(29-21)14-35-19-11-7-6-9-16(19)24(25,26)27/h6-7,9,11,15,32H,4-5,8,10,12-14H2,1-3H3 MXAWTNZDOZHUFS-UHFFFAOYSA-N 476264 US10874675, Example 7 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476264&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023154 442076329 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987426 CC(C)Cn1c2nc(COc3ccc([N+]([O-])=O)c4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H31N5O6/c1-17(2)15-31-25-24(26(34)30(3)27(31)35)28-20(11-5-4-8-14-33)21(29-25)16-38-23-13-12-22(32(36)37)18-9-6-7-10-19(18)23/h6-7,9-10,12-13,17,33H,4-5,8,11,14-16H2,1-3H3 SBNSXGFGJNCOJW-UHFFFAOYSA-N 476267 US10874675, Example 8 Malignant T-cell-amplified sequence 1 Human 300 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476267&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023155 442076332 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987427 CC(C)Cn1c2nc(COc3ccc(N)c4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H33N5O4/c1-17(2)15-32-25-24(26(34)31(3)27(32)35)29-21(11-5-4-8-14-33)22(30-25)16-36-23-13-12-20(28)18-9-6-7-10-19(18)23/h6-7,9-10,12-13,17,33H,4-5,8,11,14-16,28H2,1-3H3 OVWRROWZIQDOLP-UHFFFAOYSA-N 476268 US10874675, Example 9 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476268&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023156 442076333 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987428 CC(C)Cn1c2nc(COc3ccc4ccccc4c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H32N4O4/c1-18(2)16-31-25-24(26(33)30(3)27(31)34)28-22(11-5-4-8-14-32)23(29-25)17-35-21-13-12-19-9-6-7-10-20(19)15-21/h6-7,9-10,12-13,15,18,32H,4-5,8,11,14,16-17H2,1-3H3 FVJLJTASWKFQCP-UHFFFAOYSA-N 476269 US10874675, Example 10 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476269&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023157 442076334 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987429 CC(C)Cn1c2nc(COc3ccccc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29BrN4O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-17(10-5-4-8-12-29)18(26-21)14-32-19-11-7-6-9-16(19)24/h6-7,9,11,15,29H,4-5,8,10,12-14H2,1-3H3 LPTPYXIUNPOMTQ-UHFFFAOYSA-N 476270 US10874675, Example 11 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476270&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023158 442076335 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987430 CC(C)Cn1c2nc(COc3ccnc4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(11-5-4-8-14-32)21(29-24)16-35-22-12-13-27-19-10-7-6-9-18(19)22/h6-7,9-10,12-13,17,32H,4-5,8,11,14-16H2,1-3H3 BXPOXQVTVAQBFU-UHFFFAOYSA-N 476273 US10874675, Example 12 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476273&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023159 442076338 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987431 CC(C)Cn1c2nc(COc3ccccc3Cl)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29ClN4O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-17(10-5-4-8-12-29)18(26-21)14-32-19-11-7-6-9-16(19)24/h6-7,9,11,15,29H,4-5,8,10,12-14H2,1-3H3 FWUZRGXCRXNFIY-UHFFFAOYSA-N 476274 US10874675, Example 13 Malignant T-cell-amplified sequence 1 Human <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476274&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023160 442076339 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987432 CC(C)Cn1c2nc(COc3ccc(cc3)-c3ccccc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C29H34N4O4/c1-20(2)18-33-27-26(28(35)32(3)29(33)36)30-24(12-8-5-9-17-34)25(31-27)19-37-23-15-13-22(14-16-23)21-10-6-4-7-11-21/h4,6-7,10-11,13-16,20,34H,5,8-9,12,17-19H2,1-3H3 KNSGAEWYKVZNMJ-UHFFFAOYSA-N 476275 US10874675, Example 14 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476275&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023161 442076340 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987433 CC(C)Cn1c2nc(COc3ccccc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H30N4O4/c1-16(2)14-27-21-20(22(29)26(3)23(27)30)24-18(12-8-5-9-13-28)19(25-21)15-31-17-10-6-4-7-11-17/h4,6-7,10-11,16,28H,5,8-9,12-15H2,1-3H3 SXTDEVFFTMXSNN-UHFFFAOYSA-N 476276 US10874675, Example 15 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476276&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023162 442076341 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987434 CC(C)Cn1c2nc(COc3cccc(c3)C(F)(F)F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29F3N4O4/c1-15(2)13-31-21-20(22(33)30(3)23(31)34)28-18(10-5-4-6-11-32)19(29-21)14-35-17-9-7-8-16(12-17)24(25,26)27/h7-9,12,15,32H,4-6,10-11,13-14H2,1-3H3 ODXUMEPUIQEVLD-UHFFFAOYSA-N 476277 US10874675, Example 16 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476277&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023163 442076342 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987435 CC(C)Cn1c2nc(COc3ccccc3F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29FN4O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-17(10-5-4-8-12-29)18(26-21)14-32-19-11-7-6-9-16(19)24/h6-7,9,11,15,29H,4-5,8,10,12-14H2,1-3H3 RHNMPKYXTDYQDX-UHFFFAOYSA-N 476278 US10874675, Example 17 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476278&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023164 442076343 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987436 CC(C)Cn1c2nc(COc3ccc4ncccc4c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-21(9-5-4-6-13-32)22(29-24)16-35-19-10-11-20-18(14-19)8-7-12-27-20/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 ZRYWWBDGYKHMDR-UHFFFAOYSA-N 476279 US10874675, Example 18 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476279&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023165 442076344 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987437 CC(C)Cn1c2nc(COc3ccc(Br)cc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H28Br2N4O4/c1-14(2)12-29-21-20(22(31)28(3)23(29)32)26-17(7-5-4-6-10-30)18(27-21)13-33-19-9-8-15(24)11-16(19)25/h8-9,11,14,30H,4-7,10,12-13H2,1-3H3 QOVJUWJBUQJFHU-UHFFFAOYSA-N 476280 US10874675, Example 19 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476280&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023166 442076345 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987438 CC(C)Cn1c2nc(COc3ccc4cccnc4c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(9-5-4-6-13-32)22(29-24)16-35-19-11-10-18-8-7-12-27-21(18)14-19/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 ZRPCCABJMGSWMP-UHFFFAOYSA-N 476281 US10874675, Example 20 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476281&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023167 442076346 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987439 CC(C)Cn1c2nc(COc3ccc(Cl)cc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H28BrClN4O4/c1-14(2)12-29-21-20(22(31)28(3)23(29)32)26-17(7-5-4-6-10-30)18(27-21)13-33-19-9-8-15(25)11-16(19)24/h8-9,11,14,30H,4-7,10,12-13H2,1-3H3 ASPDTOYZUQEARO-UHFFFAOYSA-N 476282 US10874675, Example 21 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476282&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023168 442076347 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987440 CC(C)Cn1c2nc(COc3ccc(cc3)C(F)(F)F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29F3N4O4/c1-15(2)13-31-21-20(22(33)30(3)23(31)34)28-18(7-5-4-6-12-32)19(29-21)14-35-17-10-8-16(9-11-17)24(25,26)27/h8-11,15,32H,4-7,12-14H2,1-3H3 CYCYPUYYTORBNO-UHFFFAOYSA-N 476283 US10874675, Example 22 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476283&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023169 442076348 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987441 CC(C)Cn1c2nc(COc3ccccc3-c3ccccc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C29H34N4O4/c1-20(2)18-33-27-26(28(35)32(3)29(33)36)30-23(15-8-5-11-17-34)24(31-27)19-37-25-16-10-9-14-22(25)21-12-6-4-7-13-21/h4,6-7,9-10,12-14,16,20,34H,5,8,11,15,17-19H2,1-3H3 WFZKCIKHDPKHGE-UHFFFAOYSA-N 476284 US10874675, Example 23 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476284&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023170 442076349 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987442 CC(C)Cn1c2nc(COc3cc(F)ccc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H28BrFN4O4/c1-14(2)12-29-21-20(22(31)28(3)23(29)32)26-17(7-5-4-6-10-30)18(27-21)13-33-19-11-15(25)8-9-16(19)24/h8-9,11,14,30H,4-7,10,12-13H2,1-3H3 QPKWOVDQVFXBOF-UHFFFAOYSA-N 476285 US10874675, Example 24 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476285&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023171 442076350 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987443 CC(C)Cn1c2nc(COc3cccc4ccncc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(9-5-4-6-13-32)21(29-24)16-35-22-10-7-8-18-11-12-27-14-19(18)22/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 XQJJRNLAIMJUDO-UHFFFAOYSA-N 476287 US10874675, Example 25 Malignant T-cell-amplified sequence 1 Human <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476287&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023172 442076352 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987444 CC(C)Cn1c2nc(COc3cccc4cccnc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-19(11-5-4-6-14-32)20(29-24)16-35-21-12-7-9-18-10-8-13-27-22(18)21/h7-10,12-13,17,32H,4-6,11,14-16H2,1-3H3 KIFPNZPBSRAVOS-UHFFFAOYSA-N 476288 US10874675, Example 26 Malignant T-cell-amplified sequence 1 Human <500 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476288&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023173 442076353 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987445 CC(C)Cn1c2nc(COc3cc4ccccc4cn3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(11-5-4-8-12-32)21(29-24)16-35-22-13-18-9-6-7-10-19(18)14-27-22/h6-7,9-10,13-14,17,32H,4-5,8,11-12,15-16H2,1-3H3 KRVCNHKXUWJLIH-UHFFFAOYSA-N 476289 US10874675, Example 27 Malignant T-cell-amplified sequence 1 Human <500 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476289&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023174 442076354 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987446 CC(C)Cn1c2nc(COc3ccncc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C22H29N5O4/c1-15(2)13-27-20-19(21(29)26(3)22(27)30)24-17(7-5-4-6-12-28)18(25-20)14-31-16-8-10-23-11-9-16/h8-11,15,28H,4-7,12-14H2,1-3H3 HBUPYJWADTUVBN-UHFFFAOYSA-N 476291 US10874675, Example 28 Malignant T-cell-amplified sequence 1 Human <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476291&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023175 442076356 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987447 CC(C)Cn1c2nc(COc3c(Br)cc(Br)c4cnccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H29Br2N5O4/c1-15(2)13-33-24-22(25(35)32(3)26(33)36)30-20(7-5-4-6-10-34)21(31-24)14-37-23-16-8-9-29-12-17(16)18(27)11-19(23)28/h8-9,11-12,15,34H,4-7,10,13-14H2,1-3H3 JELIXQBORFHDGB-UHFFFAOYSA-N 476292 US10874675, Example 29 Malignant T-cell-amplified sequence 1 Human <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476292&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023176 442076357 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987448 CC(C)Cn1c2nc(COc3cccc4nccnc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C25H30N6O4/c1-16(2)14-31-23-22(24(33)30(3)25(31)34)28-17(8-5-4-6-13-32)19(29-23)15-35-20-10-7-9-18-21(20)27-12-11-26-18/h7,9-12,16,32H,4-6,8,13-15H2,1-3H3 CKSQCCNLTRMURI-UHFFFAOYSA-N 476293 US10874675, Example 30 Malignant T-cell-amplified sequence 1 Human <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476293&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023177 442076358 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987449 CC(C)Cn1c2nc(COc3cccnc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C22H29N5O4/c1-15(2)13-27-20-19(21(29)26(3)22(27)30)24-17(9-5-4-6-11-28)18(25-20)14-31-16-8-7-10-23-12-16/h7-8,10,12,15,28H,4-6,9,11,13-14H2,1-3H3 ITABJFLADVHYOL-UHFFFAOYSA-N 476294 US10874675, Example 31 Malignant T-cell-amplified sequence 1 Human <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476294&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023178 442076359 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987450 CC(C)Cn1c2nc(COc3cccc(c3)[N+]([O-])=O)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29N5O6/c1-15(2)13-27-21-20(22(30)26(3)23(27)31)24-18(10-5-4-6-11-29)19(25-21)14-34-17-9-7-8-16(12-17)28(32)33/h7-9,12,15,29H,4-6,10-11,13-14H2,1-3H3 NNORJQDWLVFEMM-UHFFFAOYSA-N 476295 US10874675, Example 32 Malignant T-cell-amplified sequence 1 Human <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476295&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023179 442076360 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987451 CC(C)Cn1c2nc(COc3cccc(N)c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H31N5O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-18(10-5-4-6-11-29)19(26-21)14-32-17-9-7-8-16(24)12-17/h7-9,12,15,29H,4-6,10-11,13-14,24H2,1-3H3 TUDNASVHEPSHJY-UHFFFAOYSA-N 476296 US10874675, Example 33 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476296&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023180 442076361 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987452 CC(C)Cn1c2nc(COc3ccccc3C#N)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29N5O4/c1-16(2)14-29-22-21(23(31)28(3)24(29)32)26-18(10-5-4-8-12-30)19(27-22)15-33-20-11-7-6-9-17(20)13-25/h6-7,9,11,16,30H,4-5,8,10,12,14-15H2,1-3H3 GSFWRWWJMRBIBH-UHFFFAOYSA-N 476297 US10874675, Example 34 Malignant T-cell-amplified sequence 1 Human >2000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476297&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023181 442076362 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987453 CC(C)Cn1c2nc(COc3cccc4ccccc34)c(CCc3ccccc3CO)nc2c(=O)n(C)c1=O InChI=1S/C31H32N4O4/c1-20(2)17-35-29-28(30(37)34(3)31(35)38)32-25(16-15-21-9-4-5-11-23(21)18-36)26(33-29)19-39-27-14-8-12-22-10-6-7-13-24(22)27/h4-14,20,36H,15-19H2,1-3H3 PFFZKXJCCFVGQG-UHFFFAOYSA-N 476298 US10874675, Example 35 Malignant T-cell-amplified sequence 1 Human <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL 12/29/2020 7/25/2021 THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476298&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023182 442076363 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6